Access cutting-edge hereditary cancer treatment through this clinical trial at a research site in New Brunswick. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this New Brunswick location
Preparing your pre-screening questions…
Access hereditary cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hereditary cancer treatment provided free
Check if you qualify for this hereditary cancer clinical trial in New Brunswick, NJ
No-Cost Study Care
Local to New Brunswick
Convenient for NJ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this observational study is to increase genetic education and genetic testing for hereditary cancer risk among Black cancer survivors. The study will: 1. Test the effectiveness of a chatbot intervention (also called relational agent, or RA) vs. enhanced usual care (EUC) on engagement in genetic education and requests for genetic testing. 2. Evaluate the impact of the chatbot vs. EUC on the process that participants use to make decisions and evaluate effects on well-being (also called psychosocial outcomes). 3. Explore the ways (methods) that influence how participants experience the intervention. 4. Explore the feasibility of incorporating a Family Sharing Portal (FSP) for participants who receive a positive test result, to facilitate family communication of these test results and genetic testing of first-degree biological relatives after they have received genetic education by the RA. The main questions this study aims to answer are which group - the chatbot (RA) group or the EUC group - is more likely to request genetic testing and which group is more likely to get (engage with) genetic education. Participants will be randomly assigned to either the chatbot (RA) group or EUC group. This means each participant has an equal chance of being placed in either group, just like flipping a coin. Each group will receive genetic education and have an opportunity to request genetic testing. Researchers will compare the chatbot (RA) group and the EUC group to see which may request more GT (genetic testing) and which group engages more with genetic education.
Sponsor: Rutgers, The State University of New Jersey
Yes, this clinical trial (NCT06073626) has an active research site in New Brunswick, NJ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hereditary cancer treatment options in New Brunswick, NJ, this clinical trial (NCT06073626) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Brunswick research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hereditary cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hereditary cancer clinical trials near you to find additional studies recruiting in your area.
See all erectile dysfunction clinical trials recruiting in New Brunswick — not just this study.
Browse Erectile Dysfunction Trials in New Brunswick →